Willinsky RA, Taylor SM, TerBrugge K, Farb RI, Tomlinson G, Montanera W
Until FDA approval, our priority remains offering patients safe, effective, accessible weight-loss solutions that work today. Other Non-Surgical Weight-Loss Options (Available NOW at Florida Surgery & Weight Loss) Tirzepatide (Mounjaro, Zepbound) Semaglutide (Ozempic, Wegovy) Compounded GLP-1/GIP peptides (where legally eligible) Nutritional planning & coaching Medical weight-loss evaluation Post-weight-loss surgery (Panniculectomy) options The medication does not walk the path for the patient
Limitations and controversies Dihexa literature is dominated by a small number of laboratories
It can also reduce food cravings
Another limitation is including a pair-fed group to distinguish the direct effects of semaglutide from those resulting from weight loss